Hostname: page-component-848d4c4894-pjpqr Total loading time: 0 Render date: 2024-06-24T12:08:14.943Z Has data issue: false hasContentIssue false
  • English
  • Français

Psychomotor and neurofunctional aspects after COVID-19

Published online by Cambridge University Press:  06 January 2023

Lara L. W. Chiminazzo  and
Thiago Berti Kirsten Open the ORCID record for Thiago Berti Kirsten [Opens in a new window]
Lara L. W. Chiminazzo
Affiliation:
Psychoneuroimmunology Laboratory, Program in Environmental and Experimental Pathology, Paulista University, São Paulo, Brazil
Thiago Berti Kirsten*
Affiliation:
Psychoneuroimmunology Laboratory, Program in Environmental and Experimental Pathology, Paulista University, São Paulo, Brazil
*
Author for correspondence: Thiago Berti Kirsten, Emails: thik@outlook.com, thiago.kirsten@docente.unip.br
Get access Rights & Permissions [Opens in a new window]

Abstract

Objective:

The pandemic caused by the coronavirus disease 2019 (COVID-19, SARS-CoV-2 virus) has infected more than 646 million people and caused more than 6.6 million deaths worldwide (December/2022). It is surprising that a virus that affects airways can trigger neurological manifestations. The aim of this study was to create and apply specific questionnaires/evaluations for post-COVID-19 patients to profile any neurofunctional sequelae.

Methods:

Epidemiological and psychomotor aspects as well as the intensity of cognitive, memory, attention, and concentration impairment were assessed. A total of 184 subjects post-COVID-19 and a control group (n = 30) were evaluated.

Results:

The most prevalent blood types in the COVID-19 group were the same as those from control group and in Brazilian population (no influence). Loss of smell/taste and headache were the most common reported symptoms. Talking about psychomotor and neurofunctional aspects, COVID-19 induced marked impairments in the tests: fine motor development (diadochokinesis, puppets, fan, and knead paper); balance (immobility, static balance, feet in line, and persistence); episodic memory after distractors; verbal fluency; and clock, compared to the control group data. There was also marked increase of synkinesis. Therefore, COVID-19 induced impairments in psychomotor assessments and in different cognitive aspects of the Mini-Mental State Examination. These results are more surprising considering that most participants did not report pre-existing disease and did not require hospitalisation.

Conclusion:

COVID-19 induced psychomotor, neurofunctional, and memory impairments, including in young and healthy subjects. The present study revealed neurological impairments, which should be considered in the development of rehabilitation protocols for patients affected by COVID-19.

Keywords

SARS-CoV-2neurological disordercoronaviruspandemicsABO factors
Type
Original Article
Information
Acta Neuropsychiatrica , Volume 35 , Issue 5 , October 2023 , pp. 292 - 302
Check for updates
Copyright
© The Author(s), 2023. Published by Cambridge University Press on behalf of Scandinavian College of Neuropsychopharmacology

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Ajuriaguerra, J (1974) Manuel de psychiatrie de l’enfant. Paris: Masson et cie.Google Scholar
Aprahamian, I, Martinelli, JE and Yassuda, MS (2009) Doença de Alzheimer: revisão da epidemiologia e diagnóstico [Alzheimer’s disease: an epidemiology and diagnosis review]. Revista Brasileira de Clínica Medica 7, 27–35.Google Scholar
Brasil (1990) Estatuto da criança e do adolescente : lei n. 8.069, de 13 de julho de 1990, e legislação correlata. Brasília: Senado.Google Scholar
Brêtas, J (1991) Avaliação psicomotora de crianças de 5-7 anos de idade, que frequentam a creche Maria Aparecida Carlini - Jardim Sabiá: Município de São Paulo. Master, Escola Paulista de Medicina.Google Scholar
Brito, WGF and Silva, JPDO (2020) Neuropathological impacts of COVID-19. Brazilian Journal of Health Review 3, 4227–4235.CrossRefGoogle Scholar
Burla, C, Camarano, AA, Kanso, S, Fernandes, D and Nunes, R (2013) [A perspective overview of dementia in Brazil: a demographic approach]. Ciencia & Saude Coletiva 18(10), 2949–2956.Google Scholar
CDC (2020) COVID-19 [Online]. Atlanta: Centers for Disease Control and Prevention, U.S. Department of Health & Human Services. Available at https://www.cdc.gov/coronavirus/2019-ncov/index.html 20 October 2020.Google Scholar
Chiminazzo, LLW (2022) Aspectos psicomotores e neurofuncionais após Covid-19. Master, Universidade Paulista.Google Scholar
Corrêa, D (2021) Fiocruz: aumento de casos de covid de 30 a 59 anos supera 1.000% [Online]. Rio de Janeiro: Agência Brasil. Available at https://agenciabrasil.ebc.com.br/saude/noticia/2021-04/fiocruz-aumento-de-casos-de-covid-de-30-a-59-anos-supera-1000 08 December 2021.Google Scholar
Costallat, DM (1985) Psicomotricidade. Rio de Janeiro: Globo.Google Scholar
Cuesta, GP (2005) El niño inquieto. Quito: Centro Nacional de Epilepsia.Google Scholar
Fonseca, V (2022) Manual de observação psicomotora – significação psiconeurológica. Rio de Janeiro: Wak.Google Scholar
Greco, S, Fabbri, N, Bella, A, Bonsi, B, Violi, A, Fortunato, V, Govoni, M, Graldi, G and Passaro, A (2021) COVID-19 and blood groups: a six-months observational study in Ferrara, Italy. Hematology Reports 13(3), 9177.CrossRefGoogle ScholarPubMed
Guan, WJ, Ni, ZY, Hu, Y, Liang, WH, Ou, CQ, He, JX, Liu, L, Shan, H, Lei, CL, Hui, DSC, Du, B, Li, LJ, Zeng, G, Yuen, KY, Chen, RC, Tang, CL, Wang, T, Chen, PY, Xiang, J, Li, SY, Wang, JL, Liang, ZJ, Peng, YX, Wei, L, Liu, Y, Hu, YH, Peng, P, Wang, JM, Liu, JY, Chen, Z, Li, G, Zheng, ZJ, Qiu, SQ, Luo, J, Ye, CJ, Zhu, SY, Zhong, NS and China Medical Treatment Expert Group For Covid-19 (2020) Clinical characteristics of coronavirus disease 2019 in China. New England Journal of Medicine 382(18), 1708–1720.CrossRefGoogle ScholarPubMed
Guilmain, E and Guilmain, G (1986) L’activité psychomotrice de l’enfant: son évolution de la naissance à 12 ans: tests d’âge moteur et tests psycho-moteurs. Paris: Librairie Medicale Vigne.Google Scholar
Hemocentro (2018) Prevalência dos Tipos Sanguíneos na População Brasileira [Online]. São Paulo: Santa Casa de Misericórdia de São Paulo. Available at https://www.santacasasp.org.br/portal/site/doe-sangue/pub/4587/web-site-hemocentro-sangue-tipo-sanguineo 10 July 2021.Google Scholar
JHU (2022) COVID-19 Dashboard by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University (JHU) [Online]. Baltimore: Johns Hopkins University. Available at https://coronavirus.jhu.edu/map.html 03 June 2022.Google Scholar
Kumar, A, Pareek, V, Prasoon, P, Faiq, MA, Kumar, P, Kumari, C and Narayan, RK (2020) Possible routes of SARS-CoV-2 invasion in brain: in context of neurological symptoms in COVID-19 patients. Journal of Neuroscience Research 98(12), 2376–2383.CrossRefGoogle ScholarPubMed
Li, YC, Bai, WZ and Hashikawa, T (2020) The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients. Journal of Medical Virology 92(6), 552–555.CrossRefGoogle ScholarPubMed
Luria, A (1984) El Cérebro em Acción. Barcelona: Martinez Roca..Google Scholar
Nitrini, R, Helena Lefèvre, B, Mathias, SC, Caramelli, P, Carrilho, PEM, Sauaia, N, Massad, E, Takiguti, C, Da Silva, IO, Porto, CS, Magila, MC and Scaff, M (1994) [Neuropsychological tests of simple application for diagnosing dementia]. Arquivos de Neuro-Psiquiatria 52(4), 457–465.CrossRefGoogle ScholarPubMed
Peckham, H, De Gruijter, NM, Raine, C, Radziszewska, A, Ciurtin, C, Wedderburn, LR, Rosser, EC, Webb, K and Deakin, CT (2020) Male sex identified by global COVID-19 meta-analysis as a risk factor for death and ITU admission. Nature Communications 11(1), 6317.CrossRefGoogle ScholarPubMed
Rossel, G (1975) Manuel d’éducation psycho-motrice. Paris: Masson Éditeurs.Google Scholar
Shi, Y, Wang, Y, Shao, C, Huang, J, Gan, J, Huang, X, Bucci, E, Piacentini, M, Ippolito, G and Melino, G (2020) COVID-19 infection: the perspectives on immune responses. Cell Death and Differentiation 27(5), 1451–1454.CrossRefGoogle ScholarPubMed
Takahashi, T, Ota, M, Numata, Y, Kitabatake, A, Nemoto, K, Tamura, M, Ide, M, Matsuzaki, A, Kaneda, Y and Arai, T (2022) Relationships between the Fear of COVID-19 Scale and regional brain atrophy in mild cognitive impairment. Acta Neuropsychiatrica 34(3), 153–162.CrossRefGoogle ScholarPubMed
Taquet, M, Luciano, S, Geddes, JR and Harrison, PJ (2021) Bidirectional associations between COVID-19 and psychiatric disorder: retrospective cohort studies of 62 354 COVID-19 cases in the USA. Lancet Psychiatry 8(2), 130–140.CrossRefGoogle ScholarPubMed
Taquet, M, Sillett, R, Zhu, L, Mendel, J, Camplisson, I, Dercon, Q and Harrison, PJ (2022) Neurological and psychiatric risk trajectories after SARS-CoV-2 infection: an analysis of 2-year retrospective cohort studies including 1 284 437 patients. Lancet Psychiatry 9(10), 815–827.CrossRefGoogle ScholarPubMed
Team, CC-R (2020) Preliminary estimates of the prevalence of selected underlying health conditions among patients with coronavirus disease 2019 - United States, February 12-March 28, 2020. Morbidity and Mortality Weekly Report 69, 382–386.Google Scholar
Unsworth, N, Fukuda, K, Awh, E and Vogel, EK (2014) Working memory and fluid intelligence: capacity, attention control, and secondary memory retrieval. Cognitive Psychology 71, 1–26.CrossRefGoogle ScholarPubMed
Van De Moortele, V and Deseint, F (1999) Neuro-psycho-motricité: Complémentarité de la neuropsychologie et de la psychomotricité auprès de personnes victimes d’un traumatisme crânien grave: Traumatisés crâniens. Evolutions Psychomotrices 43, 29–35.Google Scholar
WHO (2000) Cross-national comparisons of the prevalences and correlates of mental disorders. WHO International Consortium in Psychiatric Epidemiology. Bulletin of the World Health Organization 78, 413–426.Google Scholar
WHO (2020) Coronavirus Disease (COVID-19) Pandemic [Online]. Geneva: World Health Organization. Available at https://www.who.int/emergencies/diseases/novel-coronavirus-2019 21 December 2020.Google Scholar
Wu, Y, Xu, X, Chen, Z, Duan, J, Hashimoto, K, Yang, L, Liu, C and Yang, C (2020) Nervous system involvement after infection with COVID-19 and other coronaviruses. Brain Behavior and Immunity 87, 18–22.CrossRefGoogle ScholarPubMed
Xie, Y, Xu, E and Al-Aly, Z (2022) Risks of mental health outcomes in people with covid-19: cohort study. BMJ 376, e068993.CrossRefGoogle ScholarPubMed
Yu, J, Chai, P, Ge, S and Fan, X (2020) Recent understandings toward coronavirus disease 2019 (COVID-19): from bench to bedside. Frontiers in Cell and Developmental Biology 8, 476.CrossRefGoogle ScholarPubMed
Zhao, J, Yang, Y, Huang, H, Li, D, Gu, D, Lu, X, Zhang, Z, Liu, L, Liu, T, Liu, Y, He, Y, Sun, B, Wei, M, Yang, G, Wang, X, Zhang, L, Zhou, X, Xing, M and Wang, PG (2021) Relationship between the ABO blood group and the coronavirus disease 2019 (COVID-19) susceptibility. Clinical Infectious Diseases 73(2), 328–331.CrossRefGoogle ScholarPubMed
Supplementary material: PDF

Chiminazzo and Kirsten supplementary material

Chiminazzo and Kirsten supplementary material

Download Chiminazzo and Kirsten supplementary material(PDF)
PDF 160.2 KB